Selectively Agonizing Treg in Type 1 Diabetes with IL-2 Muteins

被引：1
|
作者：
Khoryati, Liliane
Kumari, Swarnima
Pham, Thi Minh Nguyet
Bogdani, Marika
Gavin, Marc
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-314-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
    Ghelani, Aazam
    Bates, Darren
    Conner, Kip
    Wu, Min-Zu
    Lu, Jiamiao
    Hu, Yi-Ling
    Li, Chi-Ming
    Chaudhry, Ashutosh
    Sohn, Sue J.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] IL-2 antibodies in type 1 diabetes and during IL-2 therapy
    Churlaud, Guillaume
    Rosenzwajg, Michelle
    Cacoub, Patrice
    Saadoun, David
    Valteau-Couanet, Dominique
    Chaput, Nathalie
    Pugliese, Alberto
    Klatzmann, David
    DIABETOLOGIA, 2018, 61 (09) : 2066 - 2068
  • [3] IL-2 antibodies in type 1 diabetes and during IL-2 therapy
    Guillaume Churlaud
    Michelle Rosenzwajg
    Patrice Cacoub
    David Saadoun
    Dominique Valteau-Couanet
    Nathalie Chaput
    Alberto Pugliese
    David Klatzmann
    Diabetologia, 2018, 61 : 2066 - 2068
  • [4] Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
    Baeyens, Audrey
    Perol, Louis
    Fourcade, Gwladys
    Cagnard, Nicolas
    Carpentier, Wassila
    Woytschak, Janine
    Boyman, Onur
    Hartemann, Agnes
    Piaggio, Eliane
    DIABETES, 2013, 62 (09) : 3120 - 3131
  • [5] IL-2 therapy in type 1 diabetes: "Trials" and tribulations
    Long, S. Alice
    Buckner, Jane H.
    Greenbaum, Carla J.
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 324 - 331
  • [6] Loss of immune tolerance to IL-2 in type 1 diabetes
    Louis Pérol
    John M. Lindner
    Pamela Caudana
    Nicolas Gonzalo Nunez
    Audrey Baeyens
    Andrea Valle
    Christine Sedlik
    Delphine Loirat
    Olivier Boyer
    Alain Créange
    José Laurent Cohen
    Ute Christine Rogner
    Jun Yamanouchi
    Martine Marchant
    Xavier Charles Leber
    Meike Scharenberg
    Marie-Claude Gagnerault
    Roberto Mallone
    Manuela Battaglia
    Pere Santamaria
    Agnès Hartemann
    Elisabetta Traggiai
    Eliane Piaggio
    Nature Communications, 7
  • [7] Loss of immune tolerance to IL-2 in type 1 diabetes
    Perol, Louis
    Lindner, John M.
    Caudana, Pamela
    Nunez, Nicolas Gonzalo
    Baeyens, Audrey
    Valle, Andrea
    Sedlik, Christine
    Loirat, Delphine
    Boyer, Olivier
    Creange, Alain
    Cohen, Jose Laurent
    Rogner, Ute Christine
    Yamanouchi, Jun
    Marchant, Martine
    Leber, Xavier Charles
    Scharenberg, Meike
    Gagnerault, Marie-Claude
    Mallone, Roberto
    Battaglia, Manuela
    Santamaria, Pere
    Hartemann, Agnes
    Traggiai, Elisabetta
    Piaggio, Eliane
    NATURE COMMUNICATIONS, 2016, 7
  • [8] Response to IL-2 signalling is specifically impaired in type 1 diabetes
    Prietl, B.
    Kofler, S.
    Stanzer, S.
    Brezinsek, H.
    Munzker, J.
    Pieber, T.
    Sourij, H.
    DIABETOLOGIA, 2017, 60 : S204 - S204
  • [9] CYTOKINES IL-2 AND IL-6 IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
    Sapunar, A.
    Markic, Josko
    Culic, S.
    Unic, I.
    Bosnjak, N.
    Kurtovic, A. Rodin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S391 - S391
  • [10] The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with 1 diabetes
    Dong, Shen
    Hiam-Galvez, Kamir J.
    Mowery, Cody T.
    Herold, Kevan C.
    Gitelman, Stephen E.
    Esensten, Jonathan H.
    Liu, Weihong
    Lares, Angela P.
    Leinbach, Ashley S.
    Lee, Michael
    Nguyen, Vinh
    Tamaki, Stanley J.
    Tamaki, Whitney
    Tamaki, Courtney M.
    Mehdizadeh, Morvarid
    Putnam, Amy L.
    Spitzer, Matthew H.
    Ye, Chun Jimmie
    Tang, Qizhi
    Bluestone, Jeffrey A.
    JCI INSIGHT, 2021, 6 (18)
12345